Navigation Links
CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
Date:6/16/2009

pent on the development of these expensive validations.

About IVT:

The Institute of Validation Technology (IVT) Conference Division features the most-notable validation and compliance experts in the FDA regulated industry. IVT stands alone in its quest to continually educate pharmaceutical, biopharmaceutical and medical device professionals in validation concepts from A-Z, AND global GXP regulatory initiatives. Through over 15 years of providing timely, cutting-edge conferences, IVT's philosophy remains that: "each of our events provides valuable take-home knowledge that can be immediately implemented at every level."

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine(R) which is currently being readied for a global Phase III trial. The Company has operations in Vienna, Virginia, and Baltimore, Maryland.

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation's SEC filings, including but not limited to its report on Form 10- K/A for the year ended September 30, 2008. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereo
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
2. CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
3. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
4. CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
5. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
6. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
7. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
8. CEL-SCI Corporation Releases Letter to Shareholders
9. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
10. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
11. Scientists advance safety of nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 At the ... and Beyond,” leaders in addiction treatment met today in ... in best clinical practices. Among the numerous respected speakers ... who will address the role that pain medications have ... new evidence-based treatment options. , "It is hard to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
(Date:3/5/2015)... 2015 As a result of ... of Clearstream, LLC ’s products, services and ... line of products—led by their mPulse Hand Sanitizer—fits ... Program. , The AAPA—which represents a profession comprising ... and surgical specialties in the U.S.—advocates and educates ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4
... Based on a survey of thousands of medical ... from Los Angles Biomedical Research Institute at Harbor-UCLA Medical ... guide to the top 1 percent of physicians in ... Top Doctors," chose another 16 LA BioMed physician-researchers as ...
... to dialysis after a kidney transplant failure survive just ... few choose that option, according to new research by ... Despite medical advances, transplanted kidneys don,t last a ... dialysis. These patients are at higher risk for complications ...
... A new study by Ohio State University cancer researchers ... two kinds of targeted agents, one that inhibits an ... reverses changes that silence genes that normally prevent cancer. ... evaluated individually in clinical trials, the researchers note. The ...
... The more you walk, the lower your risk of diabetes, ... who participated in a study to map diabetes levels across ... at the start of the study and provided details about ... given a pedometer and instructed how to use it. ...
... the 2011 AIUM Annual Convention and Preconvention Program, the ... to all disciplines of medical ultrasound, to be held ... 2011 convention program incorporates an unprecedented selection of scientific ... with a focus on emerging applications and patient safety. ...
... Serena Gordon HealthDay Reporter , THURSDAY, Jan. 13 ... SAT that,s got your teen,s stomach tied up in knots, ... scores. New research, published in the Jan. 14 issue ... minutes writing about their test anxiety and fears just before ...
Cached Medicine News:Health News:LA BioMed researchers among 'America's Top Doctors' 2Health News:Home dialysis effective for kidney patients after transplant fails 2Health News:Study provides molecular rationale for combining targeted agents to treat breast cancer 2Health News:The More You Walk, the Lower Your Diabetes Risk: Study 2Health News:AIUM unveils original features at 2011 convention 2Health News:Write Your Test Stress Away 2Health News:Write Your Test Stress Away 3
(Date:3/5/2015)...  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, ... automated DNA-based molecular analyses, announces that it is ... utilizes cutting edge technology, including next- generation DNA ... women are diagnosed with cervical cancer in ... Papillomaviruses (HPV) are a group of more than ...
(Date:3/5/2015)... YORK , March 5, 2015  Relmada ... novel therapies for the treatment of chronic pain, ... and researchers to advisory roles. The panel of ... development programs and efforts to advance the company ... pain. They bring expertise in a range of ...
(Date:3/5/2015)... LAWRENCEVILLE, N.J. , March 5, 2015 /PRNewswire/ ... today that the Company will host a conference ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. ET on Thursday, March 12, 2015. To ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... 2012  Psyche Systems Corporation today announced another first ... company that provided the industry,s first true client-server ... user interface to the pathology laboratory and the ... MicroPath is a purpose-built, full-featured, ...
... 2012   Applied Instrument Technologies (AIT), a ... petrochemical, chemical, steel, biotechnology and emissions markets has ... renewal of ISO 9001 certification, the most widely ... a priority in continuing their leadership position in ...
Cached Medicine Technology:Psyche Systems Announces Availability of MicroPath, the First LIS for Microbiology 2Applied Instrument Technologies Renews ISO 9001 Certification 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: